← Back to Search

Behavioral Intervention

Melanated Group Midwifery Care for Maternal Care (MGMC Trial)

N/A
Recruiting
Led By Stacie L Geller, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
15 years old or older
Less than 20 weeks pregnant
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year postpartum (t6)
Awards & highlights

MGMC Trial Summary

This trial is testing a new way of delivering maternity care to see if it can improve trust and engagement among Black patients.

Who is the study for?
This trial is for English-speaking pregnant women who identify as Black, are less than 20 weeks pregnant, and at least 15 years old. They must be new to prenatal care at the University of Chicago Medical Center. Black midwives, care coordinators, and community postpartum doulas from the same center can also join.Check my eligibility
What is being tested?
The study tests a Melanated Group Midwifery Care model to see if it boosts trust and engagement in Black birthing individuals during maternity care by comparing their experiences with standard practices.See study design
What are the potential side effects?
Since this trial involves patient care patterns rather than medication or medical procedures, traditional side effects are not applicable. However, there may be differences in satisfaction or emotional responses to different care models.

MGMC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 15 years old or older.
Select...
I am less than 20 weeks pregnant.

MGMC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year postpartum (t6)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year postpartum (t6) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Engagement-Postnatal adequacy
Patient Engagement-Prenatal Adequacy
Patient Engagement-Prenatal Adherence
Secondary outcome measures
Mental Well Being
Patient Autonomy
Patient Satisfaction
+3 more
Other outcome measures
Medical Referrals
Social Referrals

MGMC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MGMC Intervention GroupExperimental Treatment1 Intervention
In the MGMC (intervention) group, pregnant women will participate in group prenatal care and have ~2-hour visits with the same two co-facilitators, a Black midwife and a Black care coordinator, along with 8-12 other Black women at a similar stage of pregnancy, for all prenatal and one postnatal care visits. The care coordinator will proactively engage with women throughout pregnancy and up to 12 months postpartum. The care coordinator helps women make appointments, sends reminders, and follows-up to ensure care was received, understood, and was appropriate. In the 3rd trimester, women in MGMC will be introduced to a community-based postpartum doula. The doula will make home visits once before birth and within the first 2 weeks postpartum; they will have approximately 50 contact hours available for 12 months postpartum for primarily in-person support, but they will be available by phone and text.
Group II: Usual CareActive Control1 Intervention
In the usual care (comparator) group, pregnant women attend individually scheduled visits with a midwife or obstetrician for a physical assessment and counseling. Although this can vary by provider, continuity of care is rare and racial concordance is not a consideration. Referrals for medical or social services are given to the patient to complete in both prenatal and postnatal care.

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
608 Previous Clinical Trials
1,558,817 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
550 Previous Clinical Trials
29,996,516 Total Patients Enrolled
University of ChicagoOTHER
1,004 Previous Clinical Trials
819,359 Total Patients Enrolled

Media Library

Melanated Group Midwifery Care (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05365815 — N/A
Maternal Care Patterns Research Study Groups: Usual Care, MGMC Intervention Group
Maternal Care Patterns Clinical Trial 2023: Melanated Group Midwifery Care Highlights & Side Effects. Trial Name: NCT05365815 — N/A
Melanated Group Midwifery Care (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05365815 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who has the eligibility to participate in this research study?

"Per the study's criteria, eligible participants must have maternal care patterns and be between 15 to 49 years old. Out of these candidates, 432 will ultimately be accepted into this trial."

Answered by AI

What primary objective is this trial seeking to accomplish?

"The primary observation of this study, which is to be performed over the span of three months (T3), will assess Patient Engagement-Prenatal Adequacy. Secondary endpoints include patient activation as measured by a thirteen item scale from 0 to 100, provider trust assessed using an eleven item Likert scale ranging from one to five and patient autonomy evaluated using a seven point range of complete disagreement or agreement."

Answered by AI

Is there still the opportunity to join this experiment?

"This study, which has been listed on clinicaltrials.gov since June 7th 2022 and was last edited May 3rd 2022 is not presently looking for patients; however, 79 other trials are recruiting now."

Answered by AI

Does the current trial include geriatric individuals?

"All individuals between the age range of 15 and 49 years old are eligible to be enrolled in this trial."

Answered by AI
~221 spots leftby May 2026